Hepatitis B surface antigen (HBsAg) prevalence in Senegal
Senegal: Hepatitis B surface antigen (HBsAg) prevalence was 0.4% in 2024. ▼ Falling
Hepatitis B surface antigen (HBsAg) prevalence in Senegal, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Senegal is 0.4%, measured in 2024. That is the lowest value across all 10 years on record.
That represents a change of down 20.0% on the previous year and down 55.6% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Senegal peaked at 0.9% in 2015 and was at its lowest, 0.4%, in 2024.
Senegal ranks 62nd of 194 countries on this measure, in the middle of the range.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.8% | 0.7% | 0.9% | 5 |
| 2020s | 0.5% | 0.4% | 0.6% | 5 |
Countries ranked near Senegal
- 59 Yemen 0.5% compare
- 59 Cyprus 0.5% compare
- 59 Eritrea 0.5% compare
- 62 United Republic of Tanzania 0.4% compare
- 62 Samoa 0.4% compare
- 62 Zambia 0.4% compare
- 62 Burundi 0.4% compare
- 62 Bangladesh 0.4% compare
- 62 Iraq 0.4% compare
- 62 Cambodia 0.4% compare
- 62 Democratic People's Republic of Korea 0.4% compare
More health data for Senegal
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7598 % change on previous year (2090)
- Heat deaths vs projected death rates 835.5 (2090)
- Un projection of annual infant deaths 2,496 (2100)
- Population ages 65 and above, total, annual growth rate 3.13 % change on previous year (2025)
- Population ages 65 and above, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, total, per capita 0.0365 units per person (2025)
- Population, female, annual growth rate 2.42 % change on previous year (2025)
- Population, female, per unit of GDP 0.0003 units per US$ of GDP (2025)
- Population, female, per capita 0.4921 units per person (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Senegal?
- Hepatitis b surface antigen (hbsag) prevalence in Senegal was 0.4% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Senegal?
- The highest recorded value was 0.9% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Senegal?
- The lowest recorded value was 0.4% in 2024.
- How does Senegal rank for hepatitis b surface antigen (hbsag) prevalence?
- Senegal ranks 62nd out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Senegal?
- Over the last ten years it is down 55.6%. The long-run trend across the full record is falling.
- Where does this Senegal data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).